Drug Approval | October 18, 2023
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Increased capability to produce medicines for challenging diseases including cancer
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Subscribe To Our Newsletter & Stay Updated
